| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1990 | 2019 | |||||||||
|
thymoma | 0.686 | 0.500 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2020 | |||||||||
|
Hashimoto thyroiditis | 0.505 | 0.731 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2017 | 2019 | |||||||||
|
microRNA 150 | 0.455 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2019 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2015 | 2018 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2007 | |||||||||
|
interferon, type 1, cluster | 0.565 | 0.731 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2017 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2017 | |||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 | |||||||||
|
immunoglobulin heavy constant gamma 3 (G3m marker) | 0.513 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | |||||||||
|
microRNA 125a | 0.480 | 0.769 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2016 | 2018 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2017 | |||||||||
|
transient erythroblastopenia of childhood | 0.659 | 0.577 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
complement component 4B (Chido blood group), copy 2 | 0.670 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
long intergenic non-protein coding RNA, regulator of reprogramming | 0.548 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
IFNG antisense RNA 1 | 0.659 | 0.654 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2012 | 2012 | |||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||
|
Myasthenia gravis with thymus hyperplasia | 1.000 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
prostate androgen-regulated transcript 1 | 0.483 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1979 | 1979 |